Childrens Cancer Therapy Development Institute
HILLSBORO, OR
Total revenue
$2.4M
Total expenses
$2.7M
Net assets
$2.1M
Grants received
$3.8M
68 grants
EIN
465759569
Tax year
2024
Mission
To make all childhood cancers universally survivable by delivering new treatments to clinical trials through scientific discovery.
Financials
FY 2024
Revenue
Expenses
People
15 listed
CHARLES KELLER
Science Dir.
$313K
40 hrs/wk
CLAIRE NEWMAN
Executive Dir.
$74K
40 hrs/wk
JOHN GRANT
Board Chair
—
0.5 hrs/wk
PAUL METZGAR
Co-Treasurer
—
0.5 hrs/wk
DAVID DILTS
Co-Treasurer
—
0.5 hrs/wk
JASON MCGILL
Co-Treasurer
—
0.5 hrs/wk
GARY NAGAMORI
Compliance Off.
—
0.5 hrs/wk
MICHELLE METZGAR
Chair Elect
—
0.5 hrs/wk
MICHAEL LIN
BOARD MEMBER
—
0.5 hrs/wk
LEVI SEED
BOARD MEMBER
—
0.5 hrs/wk
LISA HOWARD
BOARD MEMBER
—
0.5 hrs/wk
KENYA ROBERTSON
BOARD MEMBER
—
0.5 hrs/wk
CHRIS RASMUSSEN
BOARD MEMBER
—
0.5 hrs/wk
TINA RICHARDS-LYNN
BOARD MEMBER
—
0.5 hrs/wk
TONIA ROGERS
BOARD MEMBER
—
0.5 hrs/wk
Grants received
Showing 68 of 68
Funded by
$3.8M from 32 funders · 68 grants · 2017–2024
$889K · 7 grants · 2018–2023
$708K · 4 grants · 2022–2024
$320K · 2 grants · 2019–2020
$264K · 2 grants · 2018–2019
$233K · 3 grants · 2020–2023
$200K · 2 grants · 2020
$161K · 1 grant · 2018
$150K · 3 grants · 2020–2021